Age shock index and age-modified shock index are strong predictors of outcomes in ST-segment elevation myocardial

Insights

New age shock index (age SI) and age-modified shock index (age MSI) effectively predict mortality in ST-elevation myocardial infarction (STEMI) patients. These simpler indicators outperform traditional shock index and GRACE score for risk stratification.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Clinical Risk Prediction

Background:

  • Early identification of high-risk patients is crucial for timely clinical intervention and disease management.
  • Predictive values of age-modified shock index (age MSI) and age shock index (age SI) in ST-segment elevation myocardial infarction (STEMI) patients undergoing emergency percutaneous coronary intervention (PCI) are not well-established.
  • Comparison with traditional shock index (SI), modified shock index (MSI), and the Global Registry of Acute Coronary Events (GRACE) risk score is needed.

Purpose of the Study:

  • To evaluate the predictive performance of age SI and age MSI for cardiovascular events and mortality in STEMI patients undergoing emergency PCI.
  • To compare the predictive capabilities of age SI and age MSI against SI, MSI, and the GRACE risk score.

Main Methods:

  • Retrospective cohort study analyzing 983 STEMI patients who underwent emergency PCI.
  • Data collected between January 2014 and September 2017.
  • Primary outcomes included in-hospital cardiovascular events, and 6-month and long-term all-cause mortality.

Main Results:

  • Age SI and age MSI demonstrated superior predictive value for in-hospital cardiac mortality, 6-month mortality, and long-term mortality compared to SI and MSI.
  • The predictive performance of age SI and age MSI was comparable to the GRACE risk score for most outcomes.
  • Multivariate analyses showed significant predictive values for age SI and age MSI (e.g., age MSI ROC-AUC = 0.84 for long-term mortality).

Conclusions:

  • Age SI and age MSI are robust predictors of cardiovascular events and mortality in STEMI patients undergoing emergency PCI.
  • These novel indices offer a simpler and potentially more convenient alternative to the GRACE score for risk stratification.
  • Age SI and age MSI provide enhanced predictive power over traditional SI and MSI.
Abstract

Related Concept Videos

Shock Waves01:16

Shock Waves

While deriving the Doppler formula for the observed frequency of a sound wave, it is assumed that the speed of sound in the medium is greater than the source's speed through it. When this condition is breached, a shock wave occurs.
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
2.5K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
192
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
636
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
246
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
235
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
202